mr NICHOLAS MANETTO

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Policies to support collaboration with Department of Veterans Affairs.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Possible reconciliation legislation, site neutrality, policies pertaining to premium subsidies, and implementation of Medicaid policies in H.R. 1.

Policies pertaining to rare disease therapy development; upcoming FDA Prescription Drug User Fee Act (PDUFA) reauthorization

FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.

Pharmacy Benefit Manager (PBM) reform legislation including provisions included in the Consolidated Appropriations Act; legislation pertaining to PBM ownership models; policies around other elements of the pharmaceutical supply chain; Trump Rx initiative.

PBM reform issues including provisions applying to Medicare and Medicaid

Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; Federal funding for primary immunodeficiency research; Federal newborn screening policies; H.R. 8425, Strengthening the Vaccines for Children Program Act.

H.R. 8528 PI Post-Acute Access Act and policies to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.

FY 26 and FY 27 inflammatory bowel disease (IBD) research, public health and therapy development policy priorities.

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus; Issues pertaining to the FDA review of therapies to treat pediatric IBD.

Policies to support child health research priorities via FY 27 appropriations process.

Legislation to strengthen how NIH supports child health research including FY 27 report language; Proposed OMB Regulation for Federal Financial Assistance, policies pertaining to indirect rates, support for multi-year research grants, and career development awards.

Support for pediatric mental health programs, Proposed OMB Regulation for Federal Financial Assistance, legislation relating to online policies and children; Pediatric organ transplantation issues.

Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.

FY 27 community project funding

FY 27 community project funding.

FY 26 and FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH (Agency for Healthcare Research and Quality (AHRQ) and other HHS agencies); grant terminations. Funding for the Childrens Hospital Graduate Medical Education (CHGME) program; Food and Drug Administration and policies pertaining to development of therapies to treat children with rare diseases; Proposed OMB Regulation for Federal Financial Assistance; PDUFA VIII policies; Policies to improve cancer screening recommendations.

FY 27 community project funding

340B program policies, policies and funding for rural healthcare services including the Rural Health Transformation Fund

Reimbursement for applications for COVID-19 emergency costs

PBM reform issues including provisions applying to Medicare and Medicaid

Pharmacy Benefit Manager (PBM) reform legislation including provisions included in the Consolidated Appropriations Act; legislation pertaining to PBM ownership models; policies around other elements of the pharmaceutical supply chain; Trump Rx initiative.

The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.

FY 2027 Appropriations; Federal grant policies

Science publishing policies

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Concerns around negotiated rulemaking changes to professional degrees and impact on nursing programs; Policies to support collaboration with Department of Veterans Affairs.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Possible reconciliation legislation, site neutrality, policies pertaining to premium subsidies, and implementation of Medicaid policies in H.R. 1.

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus.

FY 26 and FY 27 inflammatory bowel disease (IBD) research, public health and therapy development policy priorities.

FY 27 community project funding

Out-of-state Medicaid access issues and implementation of the Accelerating Kids Access to Care Act

Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.

Accelerating Kids' Access to Care Act (S. 752/H.R. 1509) and the Consolidated Appropriations Act; Implementation of Act via rulemaking process.

FY 26 and FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH (Agency for Healthcare Research and Quality (AHRQ) and other HHS agencies); grant terminations. Funding for the Childrens Hospital Graduate Medical Education (CHGME) program; Food and Drug Administration and policies pertaining to development of therapies to treat children with rare diseases; Proposed OMB Regulation for Federal Financial Assistance.

Legislation to strengthen how NIH supports child health research including FY 27 report language; Proposed OMB Regulation for Federal Financial Assistance, policies pertaining to indirect rates, support for multi-year research grants, and career development awards.

Policies to support child health research priorities via FY 27 appropriations process.

FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.

Policies pertaining to rare disease therapy development; upcoming FDA Prescription Drug User Fee Act (PDUFA) reauthorization.

Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.

Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; Federal funding for primary immunodeficiency research; Federal newborn screening policies.

Issues pertaining to FEMA Covid disaster payments

FY 27 community project funding

340B program policies, policies and funding for rural healthcare services including the Rural Health Transformation Fund

PBM reform issues including provisions applying to Medicare and Medicaid

Pharmacy Benefit Manager (PBM) reform legislation including provisions included in the Consolidated Appropriations Act; legislation pertaining to PBM ownership models; policies around other elements of the pharmaceutical supply chain; Trump Rx initiative.

Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.

Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

Accelerating Kids' Access to Care Act (S. 752/H.R. 1509) and the Consolidated Appropriations Act.

Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.

FY 27 community project funding

FY 26 and FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH (Agency for Healthcare Research and Quality (AHRQ) and other HHS agencies); grant terminations. Funding for the Childrens Hospital Graduate Medical Education (CHGME) program; Food and Drug Administration and policies pertaining to development of therapies to treat children with rare diseases.

Accelerating Kids' Access to Care Act (S. 752/H.R. 1509) and the Consolidated Appropriations Act; Implementation of Act via rulemaking process.

FY 27 community project funding.

S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; IRS issues pertaining to sharing ministries; Possible reconciliation 2.0 and other possible legislative packages.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Possible reconciliation legislation, site neutrality, policies pertaining to premium subsidies, and implementation of Medicaid policies in H.R. 1.

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Concerns around negotiated rulemaking changes to professional degrees and impact on nursing programs; Policies to support collaboration with Department of Veterans Affairs.

Reauthorization of Pediatric Priority Review Voucher and the Consolidated Appropriations Act; Rare Disease Congressional Caucus; concerns regarding FDA review of rare disease therapies; hearing preparations.

FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.

Accelerating Kids Access to Care Act (S.752/H.R. 1509) and the Consolidated Appropriations Act.

Legislation to strengthen how NIH supports child health research including FY 27 report language; reauthorization of SBIR/SBTT program, policies pertaining to indirect rates, support for multi-year research grants, and career development awards.

Policies to support child health research priorities via FY 27 appropriations process.

FY 26 and FY 27 inflammatory bowel disease (IBD) research, public health and therapy development policy priorities.

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509); Congressional Crohn's & Colitis Caucus.

FEMA payments related to COVID response; 340B program; Consolidated Appropriation Act; telehealth policy; healthcare extenders

Issues pertaining to H.R. 1 and impact on funding and payment models; Medicare and Medicaid program integrity measures.

FY 2027 Appropriations; Federal grant policies

Science publishing policies

The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.

Issues pertaining to federal healthcare policy and funding including the Medicare and Medicaid programs, 340B, telehealth, workforce/Graduate Medical Education and other issues.

Issues pertaining to federal healthcare policy and funding including the Medicare and Medicaid programs, 340B, telehealth, workforce/Graduate Medical Education and other issues.

FY 2026 Appropriations, Reconciliation

Science publishing policies

The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.

Change to NIH calculation of F&A rates; National Institutes of Health policies pertaining to child health research including opportunities to address childhood chronic diseases and opportunities within the Make America Healthy Again report and strategy; Reauthorization of Small Business Innovation Research/Small Business Technology Transfer programs.

Proposed changes to indirect cost model; Proposed changes to allocation of funding for multi-year awards

Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities; Healthcare workforce issues including the Children's Hospital Graduate Medical Education (CHGME) program; Healthcare workforce and related issues.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.

Pharmacy Benefit Manager (PBM) reform legislation; legislation pertaining to PBM ownership models; Trump Rx initiative

Issues pertaining to Transparency in Coverage regulations

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Concerns around negotiated rulemaking changes to professional degrees and impact on nursing programs.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Medicaid funding and budget reconciliation; H.R. 1/One Big Beautiful Bill; Implementation of Rural Health Transformation Fund.

FY 26 appropriations programmatic and report provisions impacting Inflammatory Bowel Disease public health, medical research and therapy development initiatives.

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509); Congressional Crohn's & Colitis Caucus.

S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; IRS issues pertaining to sharing ministries; Possible reconciliation 2.0 and other possible legislative packages.

Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.

Implementation of FDA Rare Disease Innovation Hub; reauthorization of Pediatric Priority Review Voucher; reauthorization of Newborn Screening Saves Lives Act; Activities related to PDUFA VIII; Concerns about FDA Complete Response Letters and other issues related to rare disease therapies; Activities of Congressional Rare Disease Caucus.

FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH; grant terminations. Funding for the Childrens Hospital Graduate Medical Education (CHGME) program.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and policy issues as part of H.R. 1, budget reconciliation/One Big, Beautiful Bill Act and implementation of the law.

The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.

Pharmacy Benefit Manager (PBM) reform including policies included in 2025 end-of-year package and related policies around transparency and reporting; legislation pertaining to vertical integration in healthcare.

Issues pertaining to Transparency in Coverage regulations

FY 2026 Appropriations, Reconciliation

Science publishing policies

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; SUD and behavioral health treatment policies; rural healthcare policies; issues pertaining to FEMA reimbursement; extension of expiring health policies.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Medicaid funding and budget reconciliation; H.R. 1/One Big Beautiful Bill; Implementation of Rural Health Transformation Fund.

S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; H.R. 1/OBBB budget reconciliation and possible reconciliation 2.0 opportunities; IRS issues pertaining to sharing ministries.

S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; H.R. 1/OBBB budget reconciliation and possible reconciliation 2.0 opportunities; IRS issues pertaining to sharing ministries.

Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.

FY 26 primary immunodeficiency research and public health funding.

Implementation of FDA Rare Disease Innovation Hub; reauthorization of Pediatric Priority Review Voucher; reauthorization of Newborn Screening Saves Lives Act; Activities related to PDUFA VIII.

FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

FY 26 appropriations programmatic and report provisions impacting Inflammatory Bowel Disease public health, medical research and therapy development initiatives.

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509); Congressional Crohn's & Colitis Caucus.

Legislation pertaining to insurance coverage of medical nutrition under Medicaid and other insurance programs; Medicaid funding and H.R. 1, the One Big, Beautiful Bill Act

Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities; Healthcare workforce issues including the Children's Hospital Graduate Medical Education (CHGME) program.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.

Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.

Change to NIH calculation of F&A rates; National Institutes of Health policies pertaining to child health research including opportunities to address childhood chronic diseases and opportunities within the Make America Healthy Again report and strategy.

FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH.

FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH; grant terminations. Funding for the Childrens Hospital Graduate Medical Education (CHGME) program.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and policy issues as part of H.R. 1, budget reconciliation/One Big, Beautiful Bill Act and implementation of the law.

FY 2026 Appropriations, Reconciliation

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; SUD and behavioral health treatment policies; rural healthcare policies; issues pertaining to FEMA reimbursement.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Medicaid funding and budget reconciliation; H.R. 1/One Big Beautiful Bill.

S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; H.R. 1/OBBB budget reconciliation

Issues pertaining to FEMA reimbursement

Pharmacy Benefit Manager (PBM) reform including policies included in 2025 end-of-year package and related policies around transparency and reporting; legislation pertaining to vertical integration in healthcare.

Support for client as part of Judiciary Committee hearing focused on the pharmaceutical supply chain; Policies pertaining to pharmacy benefit managers.

Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.

FY 26 primary immunodeficiency research and public health funding.

Implementation of FDA Rare Disease Innovation Hub; reauthorization of Pediatric Priority Review Voucher; reauthorization of Newborn Screening Saves Lives Act.

FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

FY 26 appropriations programmatic and report provisions impacting Inflammatory Bowel Disease public health, medical research and therapy development initiatives.

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan.

Legislation pertaining to insurance coverage of medical nutrition under Medicaid and other insurance programs; Medicaid funding and H.R. 1, the One Big, Beautiful Bill Act

Change to NIH calculation of F&A rates; National Institutes of Health policies pertaining to child health research.

FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH.

Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.

Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.

FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH; grant terminations. Funding for the Childrens Hospital Graduate Medical Education (CHGME) program.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and policy issues as part of H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.

Funding for biomedical research and changes to NIH F&A rate calculations. Make America Healthy Again commission and related policy issues pertaining to the transition.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.

FY26 appropriation requests to support research and policies related to PSP, CBD and MSA; Public policies and issues pertaining to interagency coordination and management of PSP, CBD and MSA

FY 2026 Appropriations, Reconciliation

Federal immunization and vaccine policy issues impacting the immunocompromised community; federal support for primary immunodeficiency research.

Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation.

FY 26 primary immunodeficiency research and public health funding.

Changes to NIH calculation of F&A rates; Make America Healthy Again Executive Order and Commission (includes HHS/OS). Child health and well-being and child health research issues and needs.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.

Tricare policies regarding outpatient reimbursement of children's hospitals.

2025 end-of-year healthcare package including reauthorization of the Pediatric Priority Review Voucher; legislation pertaining to FDA approval pathways; Implementation of FDA Rare Disease Innovation Hub.

FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities.

Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.

Funding for biomedical research and changes to NIH F&A rate calculations. Make America Healthy Again commission and related policy issues pertaining to the transition.

Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.

FY 25 and FY 26 appropriations public health, medical research and therapy development policies pertaining to Inflammatory Bowel Diseases (IBD). Budget reconciliation and impact on Medicaid. Legislation pertaining to access to medical foods via health insurance programs.

S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; budget reconciliation

S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; SUD and behavioral health treatment policies; rural healthcare policies.

Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Medicaid funding and budget reconciliation.

Pharmacy Benefit Manager (PBM) reform including policies included in 2025 end-of-year package and related policies around transparency and reporting; legislation pertaining to vertical integration in healthcare.

Change to NIH calculation of F&A rates; National Institutes of Health policies pertaining to child health research.

Limitation language regarding NIH F&A rates.

Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

Pediatric research and healthcare; Medicaid health funding.

H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities

Scientific meeting focused on improving diagnostics of PI.

Funding and related issue pertaining to improving diagnostics of PI; H.R. 5397, the Joe Fiandra Access to Home Infusion Act.

FY 25 Labor, HHS appropriations bill regarding the All of Us Precision Medicine program and recruitment of children.

S. 2345 and H.R. 4714, the Pediatricians Accelerate Childhood Therapies Act; Issues pertaining to recruitment and enrollment of children within the All of Us program; NIH reform modernization; Inclusion of child health activities within ARPA-H portfolio; Proposed changes to NICHD career development programs; National Academy assessment of NIH pediatric research activities.

Medical research issues pertaining to children's health and the National Institutes of Health; NIH modernization and reform proposals; SUSTAIN 340B Act; Issues pertaining to cell and gene therapies.

H.R. 4758 and S. 2372, the Accelerating Kids' Access to Care Act and issues pertaining to out-of state care for Medicaid and CHIP beneficiaries.

FY 25 appropriations legislation and provisions pertaining to coordination of rare disease activities within the FDA and HHS and funding for rare disease policies and programs including establishment of interagency rare disease coordinating committee.

Establishment of FDA Rare Disease Innovation Hub and related issues pertaining to rare disease therapy applications; reauthorization of the pediatric priority review voucher (H.R. 3433), Promising Pathways Act (S. 4426); Creating Hope Reauthorization Act of 2024 (S.4583).

Accelerating Kids' Access to Care Act (H.R. 4758, S. 2372) and issues pertaining to out-of-state care; Impact of Inflation Reduction Act on rare disease therapies.

Scientific meeting focused on improving diagnostics of PI.

Funding and related issue pertaining to improving diagnostics of PI; H.R. 5397, the Joe Fiandra Access to Home Infusion Act.

H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities

Pharmacy Benefit Manager (PBM) and pharmaceutical supply chain reform legislation across multiple bills including S. 1339, S. 127, H.R. 3561, H.R. 4507, and H.R. 4508.

H.R. 8776, the Health Care Sharing Ministry Tax Parity Act

SUSTAIN 340B Act discussion draft; H.R. 1310, the SHARE Act and issues pertaining to healthcare worker background checks; Concerns regarding the Delta Regional Authority Delta Doctor's Program; Policies to expand access to care in rural communities, policies to expand access to behavioral health services, policies to support continued access to care via telehealth; Healthcare cybersecurity issues; FEMA pandemic funding issues; Rebuild Americas Health Care Schools Act (S. 5397); HOPE Act (H.R. 9394).

Issues pertaining to rural graduate medical education program in Lugar counties and potential legislation; Policies to expand access to rural physician training programs; H.R. 4758 and S. 2372, the Accelerating Kids' Access to Care Act; Additional policies pertaining to graduate medical education; Ways and Means rural health draft legislation.

Pediatric research and healthcare; Medicaid health funding.

Funding and related issue pertaining to improving diagnostics of PI; FDA proposal to regulate Laboratory Developed Tests (LDTs); H.R. 5397, the Joe Fiandra Access to Home Infusion Act.

FY 25 report language pertaining to primary immunodeficiency disease medical research.

H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities

Issues pertaining to rural graduate medical education program in Lugar counties and potential legislation; Policies to expand access to rural physician training programs; H.R. 4758 and S. 2372, the Accelerating Kids' Access to Care Act; Additional policies pertaining to graduate medical education; Ways and Means rural health draft legislation.

SUSTAIN 340B Act discussion draft; H.R. 1310, the SHARE Act and issues pertaining to healthcare worker background checks; Concerns regarding the Delta Regional Authority Delta Doctor's Program; Policies to expand access to care in rural communities, policies to expand access to behavioral health services, policies to support continued access to care via telehealth; Healthcare cybersecurity issues; FEMA pandemic funding issues

H.R. 8776, the Health Care Sharing Ministry Tax Parity Act